Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Activin A receptor type 2B (ACVR2B) is a transmembrane serine/threonine kinase receptor belonging to the TGF-β superfamily. It binds ligands such as activin-A, activin-B, inhibin-A, and myostatin (MSTN), initiating intracellular signaling cascades that regulate diverse biological processes, including neuronal differentiation, hair follicle development, FSH production, wound healing, extracellular matrix production, immunosuppression, carcinogenesis and muscle growth regulation. ACVR2B primarily signals through SMAD2 and SMAD3.
Ligand binding induces heteromeric complex formation with type I receptors, leading to SMAD2/3 phosphorylation and activation of downstream transcriptional regulation.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Activin A Receptor Type 2B (ACVR2B).